All Stories

  1. Current Clinical Psychopharmacology in Borderline Personality Disorder
  2. Thoughts of Death, Depression and Guilt in a Healthcare Worker Who Infected Her Husband with SARS-CoV-2: A Case Report
  3. Matters on suicide and neurological diseases
  4. An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine
  5. Influence of Spiritual Dimensions on Suicide Risk: The Role of Regional Differences
  6. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
  7. Suicide Risk in Obsessive-Compulsive Disorder and Exploration of Risk Factors: A Systematic Review
  8. Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time
  9. Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
  10. Posttraumatic stress reactions of underground drivers after suicides by jumping to arriving trains; feasibility of an early stepped care outpatient intervention
  11. Neuropsychiatric disturbances in atypical parkinsonian disorders
  12. Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
  13. Mediators in the Association Between Affective Temperaments and Suicide Risk Among Psychiatric Inpatients
  14. Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate
  15. Neural Correlates in Patients with Major Affective Disorders: An fMRI Study
  16. Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
  17. Abnormalities in Kynurenine Pathway Metabolism in Treatment-Resistant Depression and Suicidality: A Systematic Review
  18. Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a Role?
  19. Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions
  20. Suicide Risk in Alzheimer’s Disease: A Systematic Review
  21. warning signs of suicide
  22. Benzodiazepine and training
  23. Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up
  24. Bisexuality and Suicide: A Systematic Review of the Current Literature
  25. Suicide in Italy during a time of economic recession: some recent data related to age and gender based on a nationwide register study
  26. Hypothalamic Pituitary Adrenal Axis and Prolactin Abnormalities in Suicidal Behavior
  27. Suicide Attempts in Major Depressed Patients with Personality Disorder
  28. Sociodemographic and Clinical Differences Between Suicide Ideators and Attempters: A Study of Mood Disordered Patients 50 Years and Older
  29. Support management in schizophrenia: a systematic review of current literature
  30. Suicide: A Global Perspective
  31. Inequalities and Impact of Socioeconomic-Cultural Factors in Suicide Rates Across Italy
  32. The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
  33. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents
  34. Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
  35. Psychiatric comorbidity and suicide risk in patients with chronic migraine
  36. Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?